This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
He quits smoking, decides to eat healthier and exercise more, and to be more compliant with his bloodpressure medications. He quits smoking, decides to eat healthier and exercise more, and to be more compliant with his bloodpressure medications. CME Test Yourself What is the most likely diagnosis?
Bakris was ahead of his time, what we would call prescient in that, although he was a nephrologist, he saw the link between the kidney, high bloodpressure, diabetes, and the overall cardiometabolic condition. Attendees will gain valuable clinical insights and explore cutting-edge therapies aimed at improving overall health outcomes.
cardiometabolic health CME/CE conference: the 19th Annual CMHC. 3 SGLT2i as Foundational Therapy for Cardio-Kidney Protection PME CME Session: “SGLT2i as Foundational Therapy for Cardio-Kidney Protection” Presenter: Erin D. SELECT Trial Results : Semaglutide 2.4
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
130 
Let's personalize your content